Skip to content
Abierto
Menu

Presolicitation

Toxicity evaluation of YC1 in hSULT1A1 and mSULT1A1 mice

75N95025Q00237

National Institutes of Health, National Institutes of Health Nida. Testing Laboratories and Services.

View on SAM.govMarkdown

Awarded

Gempharmatech LLC

$58,936.00 obligated so far on USAspending

Description

As published on SAM.gov.

NCATS seeks to determine if YC1 which works with a unique mechanism of cytotoxicity towards cancer cells that express SULT1A1. In doing so, NCATS shall establish the therapeutic window for YC1. To that end NCATS requires head-to-head comparison on YC1 in mice that have humanized SULT1A1 (custom mice available at GemPharmaTech) and with mouse SULT1A1 (wild type).

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Gempharmatech LLC
UEI
H42SCKKGRTU3
CAGE
98AV0
Vendor location
San Diego, CA
Contract
75N95025P00413, purchase order
Obligated
$58,936.00
Actions
1 between September 24, 2025 and September 24, 2025
Competition
Not Competed Under SAP, 1 offer received
Set-aside reported
No Set Aside Used.
Described as
Safety Evaluation of YC1 in Hsult1a1 and Msult1a1 Mice.
Match
solicitation number 75N95025Q00237 equals the FPDS solicitation identifier; same awarding office 75N950 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. August 12, 2025

    Presolicitation

    Due August 18, 2025 at 12:00 PM EDT. SAM.gov, notice 9297051a89bc4a30944a0f0465525a52

Points of contact

Also open from this buyer